Total Payments
$357,777
2024 Payments
$9,854
Companies
37
Transactions
648
Medicare Patients
17,724
Medicare Billing
$1.9M
Payment Breakdown by Category
Other$292,858 (81.9%)
Consulting$34,110 (9.5%)
Food & Beverage$20,540 (5.7%)
Travel$10,255 (2.9%)
Education$13.22 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $285,760 | 52 | 79.9% |
| Consulting Fee | $34,110 | 17 | 9.5% |
| Food and Beverage | $20,540 | 515 | 5.7% |
| Travel and Lodging | $10,255 | 56 | 2.9% |
| Grant | $4,025 | 2 | 1.1% |
| Honoraria | $2,500 | 1 | 0.7% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $500.00 | 1 | 0.1% |
| Entertainment | $72.84 | 2 | 0.0% |
| Education | $13.22 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $235,618 | 148 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $55,110 | 102 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $33,278 | 82 | $0 (2024) |
| PFIZER INC. | $15,134 | 47 | $0 (2024) |
| Abbott Laboratories | $8,351 | 91 | $0 (2024) |
| CARDIVA MEDICAL, INC. | $2,500 | 1 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $1,761 | 25 | $0 (2024) |
| Medtronic, Inc. | $1,235 | 15 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $1,154 | 54 | $0 (2024) |
| Medtronic Vascular, Inc. | $1,101 | 14 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $9,854 | 44 | Boston Scientific Corporation ($8,582) |
| 2023 | $8,202 | 77 | Abbott Laboratories ($3,239) |
| 2022 | $6,053 | 84 | Janssen Pharmaceuticals, Inc ($3,561) |
| 2021 | $22,217 | 102 | Janssen Pharmaceuticals, Inc ($11,402) |
| 2020 | $14,003 | 63 | Boston Scientific Corporation ($5,040) |
| 2019 | $40,525 | 95 | E.R. Squibb & Sons, L.L.C. ($13,569) |
| 2018 | $108,332 | 100 | BOSTON SCIENTIFIC CORPORATION ($76,385) |
| 2017 | $148,592 | 83 | BOSTON SCIENTIFIC CORPORATION ($124,323) |
All Payment Transactions
648 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/25/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/14/2024 | ATRICURE, INC. | ATRICLIP LAA EXCLUSION SYSTEM (Device) | Food and Beverage | In-kind items and services | $49.06 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/14/2024 | Nalu Medical, Inc. | Nalu Neurostimulation System (Device) | Food and Beverage | In-kind items and services | $31.84 | General |
| Category: Pain Management | ||||||
| 10/27/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $125.97 | General |
| Category: Lithoplasty | ||||||
| 09/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/18/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $21.57 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/09/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $28.74 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/29/2024 | Boston Scientific Corporation | EMBLEM MRI S-ICD (Device) | Food and Beverage | In-kind items and services | $157.74 | General |
| Category: EMBLEM_CRM | ||||||
| 08/08/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $23.48 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/30/2024 | Boston Scientific Corporation | BodyGuardian (Device) | Food and Beverage | In-kind items and services | $11.34 | General |
| Category: CDS - Holter Monitoring_RM | ||||||
| 07/22/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $27.43 | General |
| Category: Cardiovascular | ||||||
| 07/13/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $24.96 | General |
| 07/12/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $148.05 | General |
| Category: Cardiac Rhythm Management | ||||||
| 07/08/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/18/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $26.06 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/13/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $27.98 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/13/2024 | Boston Scientific Corporation | BodyGuardian (Device) | Food and Beverage | In-kind items and services | $3.00 | General |
| Category: CDS - Holter Monitoring_RM | ||||||
| 06/10/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/06/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/04/2024 | DePuy Synthes Sales Inc. | MATRIXRIB (Device) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: CMF-Trauma | ||||||
| 06/03/2024 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/18/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $146.26 | General |
| 05/16/2024 | Medtronic, Inc. | MICRA (Device) | Food and Beverage | In-kind items and services | $174.89 | General |
| Category: Pacemakers | ||||||
| 05/16/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $23.21 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/10/2024 | Boston Scientific Corporation | — | Consulting Fee | Cash or cash equivalent | $6,875.00 | General |
| Category: General - Therapies_CRM | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 38 | 4,343 | 6,910 | $2.2M | $439,595 |
| 2022 | 42 | 4,423 | 7,023 | $2.3M | $489,331 |
| 2021 | 44 | 4,752 | 7,229 | $2.4M | $516,653 |
| 2020 | 42 | 4,206 | 6,681 | $2.1M | $459,944 |
Total Patients
17,724
Total Services
27,843
Medicare Billing
$1.9M
Procedure Codes
177
All Medicare Procedures & Services
177 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 578 | 759 | $245,157 | $70,182 | 28.6% |
| 93656 | Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | Facility | 2023 | 76 | 76 | $259,236 | $54,298 | 20.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 173 | 468 | $111,384 | $28,963 | 26.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 172 | 174 | $127,716 | $25,291 | 19.8% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2023 | 52 | 52 | $91,000 | $19,725 | 21.7% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 520 | 1,136 | $117,008 | $17,553 | 15.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 113 | 113 | $70,286 | $17,482 | 24.9% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 389 | 829 | $91,190 | $16,932 | 18.6% |
| 33340 | Repair of left upper heart chamber with implant with review by radiologist | Facility | 2023 | 26 | 27 | $55,215 | $15,297 | 27.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 101 | 111 | $74,370 | $14,860 | 20.0% |
| 93609 | Insertion of tube in upper and/or lower heart chambers to record and identify origin of abnormal heart rhythm | Facility | 2023 | 60 | 61 | $43,493 | $12,783 | 29.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 80 | 89 | $38,715 | $12,094 | 31.2% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 272 | 426 | $42,174 | $11,121 | 26.4% |
| 33225 | Insertion of left lower heart electrode for pacemaker or defibrillator | Facility | 2023 | 32 | 32 | $48,928 | $11,121 | 22.7% |
| 33249 | Insertion of implantable defibrillator system | Facility | 2023 | 16 | 16 | $48,528 | $10,188 | 21.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 678 | 927 | $60,255 | $10,004 | 16.6% |
| 93653 | Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | Facility | 2023 | 12 | 13 | $33,215 | $7,660 | 23.1% |
| 93650 | Destruction of heart conduction tissue to create heart block | Facility | 2023 | 18 | 18 | $35,208 | $7,585 | 21.5% |
| 33228 | Removal and replacement of dual lead permanent pacemaker | Facility | 2023 | 29 | 29 | $32,190 | $7,548 | 23.4% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 136 | 296 | $63,936 | $7,265 | 11.4% |
| 93623 | Programming of heart rhythm stimulation after drug infusion | Facility | 2023 | 94 | 95 | $38,855 | $6,117 | 15.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 59 | 60 | $27,300 | $6,032 | 22.1% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 50 | 285 | $25,080 | $5,437 | 21.7% |
| 93284 | Programming of multiple lead implantable defibrillator system | Office | 2023 | 84 | 117 | $18,954 | $4,752 | 25.1% |
| 33229 | Removal and replacement of multiple lead permanent pacemaker | Facility | 2023 | 17 | 17 | $19,635 | $4,623 | 23.5% |
About Dr. Brian Le, MD
Dr. Brian Le, MD is a Cardiovascular Disease healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1235138306.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Le, MD has received a total of $357,777 in payments from pharmaceutical and medical device companies, with $9,854 received in 2024. These payments were reported across 648 transactions from 37 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($285,760).
As a Medicare-enrolled provider, Le has provided services to 17,724 Medicare beneficiaries, totaling 27,843 services with total Medicare billing of $1.9M. Data is available for 4 years (2020–2023), covering 177 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Clinical Cardiac Electrophysiology
- Location Dallas, TX
- Active Since 07/20/2005
- Last Updated 11/03/2020
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1235138306
Products in Payments
- GENERAL TACHY (Device) $70,000
- GENERAL - BRADY (Device) $62,535
- GENERAL - TACHY (Device) $56,325
- XARELTO (Drug) $55,110
- ELIQUIS (Drug) $38,395
- GENERAL - THERAPIES (Device) $9,473
- GENERAL THERAPIES (Device) $5,727
- GENERAL THERAPIES (Device) $5,410
- WATCHMAN (Device) $4,519
- GENERAL BRADY (Device) $4,000
- AVEIR (Device) $3,155
- Vascular Closure Device (Device) $2,500
- GENERAL THERAPIES (Device) $2,100
- Perclose ProGlide suture mediated closure system (Device) $1,922
- MULTAQ (Drug) $1,761
- General - Brady (Device) $1,750
- Omnilink Elite vascular stent system (Device) $1,299
- LifeVest (Device) $1,154
- Micra (Device) $712.61
- MICRA (Device) $557.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Dallas
Darren Mcguire, Md, MD
Cardiovascular Disease — Payments: $2.0M
Cardiovascular Disease $2.0M
Dr. Peter Mccullough, Md, Mph, MD, MPH
Cardiovascular Disease — Payments: $1.3M
Cardiovascular Disease $1.3M
Robert Stoler, M.d, M.D
Cardiovascular Disease — Payments: $719,078
Cardiovascular Disease $719,078
Dr. Ann Navar, Md, Phd, MD, PHD
Cardiovascular Disease — Payments: $672,005
Cardiovascular Disease $672,005
Martin Berk, M.d, M.D
Cardiovascular Disease — Payments: $493,450
Cardiovascular Disease $493,450
James De Lemos, Md, MD
Cardiovascular Disease — Payments: $448,409
Cardiovascular Disease $448,409